Kidney disease in cardiology
Charles A. Herzog
Medicine - Cardiology Division
Topics covered in this review include the relation of estimated glomerular filtration rate, proteinuria and outcome; sudden cardiac death; contrast-induced acute kidney injury (CI-AKI); imaging; clinical trials targeting cardiovascular disease in chronic kidney disease (CKD) patients; and treatment of ischemic heart disease and valvular disease. Several studies reinforce the importance of CKD in predicting mortality and make a case for redefining CKD to incorporate levels of proteinuria in the staging system. Another study provides support for using a combination of echocardiography and cardiac biomarkers for cardiac risk stratification in dialysis patients. Two studies reveal ongoing interest in and difficulty preventing CI-AKI. One study discusses chest ultrasound to detect pulmonary congestion and potentially guide ultrafiltration and volume removal in dialysis patients. Several clinical trials assess folic acid, statins and aspirin for prevention of future cardiovascular events in CKD patients. Finally, several studies compare the use of drug-eluting and bare metal stents in dialysis patients, discuss methods of surgical coronary artery revascularization in dialysis patients and describe testing allopurinol as a treatment for ischemic heart disease in non-renal patients.
Nephrology Dialysis Transplantation
https://doi.org/10.1093/ndt/gfq719
Contrast nephropathy
sudden cardiac death
valve surgery
10.1093/ndt/gfq719
Dive into the research topics of 'Kidney disease in cardiology'. Together they form a unique fingerprint.
Kidney Diseases Medicine & Life Sciences 100%
Cardiology Medicine & Life Sciences 94%
Chronic Renal Insufficiency Medicine & Life Sciences 50%
Dialysis Medicine & Life Sciences 46%
Proteinuria Medicine & Life Sciences 26%
Acute Kidney Injury Medicine & Life Sciences 25%
Myocardial Ischemia Medicine & Life Sciences 24%
Clinical Trials Medicine & Life Sciences 17%
Herzog, C. A. (2011). Kidney disease in cardiology. Nephrology Dialysis Transplantation, 26(1), 46-50. https://doi.org/10.1093/ndt/gfq719
Kidney disease in cardiology. / Herzog, Charles A.
In: Nephrology Dialysis Transplantation, Vol. 26, No. 1, 01.2011, p. 46-50.
Herzog, CA 2011, 'Kidney disease in cardiology', Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 46-50. https://doi.org/10.1093/ndt/gfq719
Herzog CA. Kidney disease in cardiology. Nephrology Dialysis Transplantation. 2011 Jan;26(1):46-50. https://doi.org/10.1093/ndt/gfq719
Herzog, Charles A. / Kidney disease in cardiology. In: Nephrology Dialysis Transplantation. 2011 ; Vol. 26, No. 1. pp. 46-50.
@article{c46318f5074347b993f47b874831e73b,
title = "Kidney disease in cardiology",
abstract = "Topics covered in this review include the relation of estimated glomerular filtration rate, proteinuria and outcome; sudden cardiac death; contrast-induced acute kidney injury (CI-AKI); imaging; clinical trials targeting cardiovascular disease in chronic kidney disease (CKD) patients; and treatment of ischemic heart disease and valvular disease. Several studies reinforce the importance of CKD in predicting mortality and make a case for redefining CKD to incorporate levels of proteinuria in the staging system. Another study provides support for using a combination of echocardiography and cardiac biomarkers for cardiac risk stratification in dialysis patients. Two studies reveal ongoing interest in and difficulty preventing CI-AKI. One study discusses chest ultrasound to detect pulmonary congestion and potentially guide ultrafiltration and volume removal in dialysis patients. Several clinical trials assess folic acid, statins and aspirin for prevention of future cardiovascular events in CKD patients. Finally, several studies compare the use of drug-eluting and bare metal stents in dialysis patients, discuss methods of surgical coronary artery revascularization in dialysis patients and describe testing allopurinol as a treatment for ischemic heart disease in non-renal patients.",
keywords = "Contrast nephropathy, ischaemic heart disease, proteinuria, sudden cardiac death, valve surgery",
author = "Herzog, {Charles A.}",
doi = "10.1093/ndt/gfq719",
journal = "Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress",
publisher = "Oxford University Press",
T1 - Kidney disease in cardiology
AU - Herzog, Charles A.
N2 - Topics covered in this review include the relation of estimated glomerular filtration rate, proteinuria and outcome; sudden cardiac death; contrast-induced acute kidney injury (CI-AKI); imaging; clinical trials targeting cardiovascular disease in chronic kidney disease (CKD) patients; and treatment of ischemic heart disease and valvular disease. Several studies reinforce the importance of CKD in predicting mortality and make a case for redefining CKD to incorporate levels of proteinuria in the staging system. Another study provides support for using a combination of echocardiography and cardiac biomarkers for cardiac risk stratification in dialysis patients. Two studies reveal ongoing interest in and difficulty preventing CI-AKI. One study discusses chest ultrasound to detect pulmonary congestion and potentially guide ultrafiltration and volume removal in dialysis patients. Several clinical trials assess folic acid, statins and aspirin for prevention of future cardiovascular events in CKD patients. Finally, several studies compare the use of drug-eluting and bare metal stents in dialysis patients, discuss methods of surgical coronary artery revascularization in dialysis patients and describe testing allopurinol as a treatment for ischemic heart disease in non-renal patients.
AB - Topics covered in this review include the relation of estimated glomerular filtration rate, proteinuria and outcome; sudden cardiac death; contrast-induced acute kidney injury (CI-AKI); imaging; clinical trials targeting cardiovascular disease in chronic kidney disease (CKD) patients; and treatment of ischemic heart disease and valvular disease. Several studies reinforce the importance of CKD in predicting mortality and make a case for redefining CKD to incorporate levels of proteinuria in the staging system. Another study provides support for using a combination of echocardiography and cardiac biomarkers for cardiac risk stratification in dialysis patients. Two studies reveal ongoing interest in and difficulty preventing CI-AKI. One study discusses chest ultrasound to detect pulmonary congestion and potentially guide ultrafiltration and volume removal in dialysis patients. Several clinical trials assess folic acid, statins and aspirin for prevention of future cardiovascular events in CKD patients. Finally, several studies compare the use of drug-eluting and bare metal stents in dialysis patients, discuss methods of surgical coronary artery revascularization in dialysis patients and describe testing allopurinol as a treatment for ischemic heart disease in non-renal patients.
KW - Contrast nephropathy
KW - ischaemic heart disease
KW - proteinuria
KW - sudden cardiac death
KW - valve surgery
U2 - 10.1093/ndt/gfq719
DO - 10.1093/ndt/gfq719
JO - Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress
JF - Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress